Last updated on November 2018

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Eczema (Atopic Dermatitis) | Prurigo Nodularis | Eczema
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Eligible male and female participants will be 18 years of age or older, have a diagnosis of PN with 10+ nodules on 2 different body parts.  Female subjects cannot plan to be pregnant or breast feeding during the study. Subjects must be available for the 9 office visits during the study and be willing to comply with all study instructions. Several other restrictions and criteria may apply that the study doctor will review with you to determine if you qualify to enter the study.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.